Dowd Scheffel Submits Amicus Brief to Supreme Court in Juno Therapeutics, Inc. v. Kite Pharma, Inc.
- Matthew Dowd
- Jun 15, 2022
- 1 min read
Dowd Scheffel submitted an Amicus Curiae brief with Laura Coruzzi on behalf of RegenexBio Inc. in the highly publicized Juno Therapeutics, Inc. v. Kite Pharma, Inc. case. The case concerns important issues for biotechnology inventions and whether the current law concerning the level of description required under the Federal Circuit's interpretation of the patent laws detrimentally impacts biotechnology innovation and investment in life saving technologies. A copy of the brief can be found at https://www.law360.com/articles/1512215/attachments/3
Recent Posts
See AllIn a recent analysis of the Google v. EcoFactor en banc rehearing, Managing Partner Matthew Dowd shared his insights on the...
Dowd Scheffel Managing Partner Matthew J. Dowd conveyed his confidence in President Trump’s appointee for PTO Director, John Squires. In...
On October 28th, Dowd Scheffel filed an amicus brief for the Honorable Paul R. Michel (ret.) in a key antitrust case involving...
Comments